Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Fluorescein TSA Fluorescence System Kit: Signal Amplifica...

    2026-02-10

    Fluorescein TSA Fluorescence System Kit: Signal Amplification in Immunohistochemistry

    Executive Summary: The Fluorescein TSA Fluorescence System Kit (K1050, APExBIO) utilizes horseradish peroxidase (HRP)-mediated deposition of fluorescein-labeled tyramide for localized fluorescence amplification in fixed samples (product page). This approach enables detection of proteins and nucleic acids at picogram levels in immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) (see benchmarking dossier). The kit is validated for robust, reproducible signal enhancement in standard fluorescence microscopy workflows (Nature Communications 2025). Fluorescein dye in the kit is excitable at 494 nm and emits at 517 nm, making it compatible with most filter sets. All reagents are stable for two years under recommended storage. The kit does not support live-cell imaging or diagnostic/clinical use.

    Biological Rationale

    Detection of low-abundance proteins and nucleic acids in fixed tissue or cell samples is critical for understanding molecular mechanisms in neuroscience, pathology, and developmental biology (Duan et al., 2025). Conventional fluorescence detection is limited by the number of fluorophores per target and background autofluorescence. Tyramide signal amplification (TSA) addresses these limitations by covalently depositing multiple fluorophores at sites of enzymatic activity, increasing local signal density (see sensitivity review). This enables visualization of targets previously undetectable by direct or indirect labeling methods. Amplified detection is essential when studying rare cell populations, weakly expressed genes, or subtle post-translational modifications. TSA fluorescence thus supports rigorous quantification in research settings where maximal sensitivity and spatial resolution are required.

    Mechanism of Action of Fluorescein TSA Fluorescence System Kit

    The kit employs a tyramide signal amplification fluorescence kit mechanism, based on HRP-catalyzed conversion of fluorescein-labeled tyramide into a short-lived, highly reactive radical. This intermediate covalently binds to electron-rich tyrosine residues on nearby proteins or nucleic acids, anchoring the fluorescent label precisely at the HRP site (benchmarking dossier). The process is initiated by primary antibody binding to the target, followed by HRP-conjugated secondary antibody binding. Upon addition of the fluorescein tyramide substrate, HRP catalyzes radical formation in the presence of hydrogen peroxide (supplied in the amplification diluent). The fluorescein tyramide is supplied as a dry reagent, to be dissolved in DMSO before use. Signal amplification occurs within minutes at room temperature. The resulting signal is highly localized, reducing background and enabling single-cell or subcellular resolution. The fluorescein dye's excitation peak at 494 nm and emission at 517 nm ensure compatibility with standard FITC filter sets and detectors (APExBIO product page).

    Evidence & Benchmarks

    • Enables detection of low-abundance proteins in fixed tissue at picogram (pg) quantities, outperforming standard indirect immunofluorescence methods (Duan et al., 2025).
    • Provides 10- to 100-fold fluorescence signal amplification in immunohistochemistry compared to conventional fluorophore-labeled secondaries (signal review).
    • Signal remains highly localized (<5 μm spread from HRP site) due to short-lived tyramide intermediates, supporting subcellular resolution (benchmarking dossier).
    • Compatible with detection of both protein and nucleic acid targets in IHC, ICC, and ISH workflows (application deep dive).
    • Kit reagents are stable for up to two years under recommended storage (fluorescein tyramide at -20°C, diluent and blocker at 4°C) (APExBIO).

    Applications, Limits & Misconceptions

    The Fluorescein TSA Fluorescence System Kit is optimized for signal amplification in immunohistochemistry, immunocytochemistry, and in situ hybridization of fixed samples. It is widely used in neuroscience for mapping rare neural markers, in pathology for detecting low-abundance disease proteins, and in gene expression studies to visualize scarce transcripts (Duan et al., 2025). The system is not designed for live-cell imaging due to the need for fixed, permeabilized samples and the covalent, irreversible deposition of tyramide. The kit is for research use only and not validated for diagnostic or clinical workflows. The high sensitivity may increase background if blocking and washing steps are insufficient. Overamplification can mask spatial relationships when used with excessive HRP or substrate concentrations.

    Common Pitfalls or Misconceptions

    • Not for live-cell imaging: The kit requires fixed, permeabilized samples; tyramide radicals damage live cells.
    • Background amplification: Inadequate blocking or excessive HRP/substrate can cause high background fluorescence.
    • Not for clinical diagnosis: The kit is strictly for research use and is not intended for medical diagnostics.
    • Overamplification: Excess amplification may obscure subcellular localization due to signal spread.
    • Limited by HRP specificity: Signal localization is only as precise as antibody/HRP specificity allows.

    Workflow Integration & Parameters

    The kit integrates into standard IHC, ICC, or ISH protocols following fixation and permeabilization. After primary and HRP-conjugated secondary antibody incubation, slides are treated with amplification diluent, blocking reagent, and the freshly prepared fluorescein tyramide solution. Incubation occurs at room temperature, typically for 5–10 minutes. Reaction is stopped by washing with buffer (e.g., PBS, pH 7.4). Signal visualization is performed using fluorescence microscopy with FITC-compatible filter sets. All steps should be performed protected from light to preserve fluorescein signal. For detailed, scenario-based protocol guidance, see this article, which provides real-world troubleshooting and optimization strategies not covered in this mechanistic overview. For a discussion of benchmarking versus other amplification systems, see this comparison—this article updates threshold limits and specificity data.

    Conclusion & Outlook

    The Fluorescein TSA Fluorescence System Kit (K1050) from APExBIO offers robust, ultrasensitive fluorescence signal amplification for fixed sample IHC, ICC, and ISH applications (product page). Its HRP-catalyzed tyramide deposition mechanism delivers high-density, localized signals for detection of low-abundance targets. The kit's compatibility with standard microscopy, stable storage, and flexibility for both protein and nucleic acid detection make it a preferred choice for advanced research. Future work may extend TSA fluorescence to multiplexed labeling and automation workflows. For a deeper exploration of the comparative advantages of TSA-based kits, see this review, which this article extends by providing mechanistic and storage stability data.